Using creatine to help treat depression in methamphetamine users
Official title: An Open-Label Pilot Study of Creatine for Depressed Male and Female Methamphetamine Users
Run by Montana State University · NCT02568878 · Data updated 2026-11-12
This study is testing if creatine can help reduce depression and anxiety in people who are dependent on methamphetamine.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 59 Years |
| Sex | All |
| Enrollment | 29 (estimated) |
| Sponsor | Montana State University Academic / other |
| Locations | 1 site (Missoula, Montana) |
| Status | Recruiting |
| Started | November 2015 |
| Main results expected | October 2016 |
| Study ends | May 2017 |
| Registry record updated | December 11, 2015 |
| Trial ID | NCT02568878 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with a primary diagnosis of methamphetamine dependence, major depressive disorder, and an anxiety disorder.
✕Probably not a fit
Patients with primary substance-related diagnoses other than methamphetamine dependence or those with significant medical or neurological illnesses may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effects of creatine monohydrate on depression and anxiety in male and female individuals who are dependent on methamphetamine. It aims to determine whether creatine can alleviate depressive symptoms and reduce methamphetamine use while also assessing its safety in this population. Participants must have a current diagnosis of methamphetamine dependence, major depressive disorder, and an anxiety disorder, with specific severity scores on standardized scales. The study will monitor the participants' responses to creatine over a defined treatment period.
Why it matters
Potential benefit: If successful, this study could provide a novel treatment option for individuals struggling with depression and methamphetamine dependence.
How similar studies have gone: While the use of creatine for depression is an emerging area of interest, this specific application in methamphetamine users is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Current primary diagnosis of methamphetamine dependence or abuse, with methamphetamine preferred drug of abuse * Current diagnosis of major depressive disorder (primary or substance-induced) * Current diagnosis of an anxiety disorder (primary or substance-induced) * Current Hamilton Depression Rating scale score \> or = to 16 * Current Hamilton Anxiety Scale score \> = to 18 * If taking a psychotropic medication for depressed or anxious mood, regimen must be stable for \> = to 4 weeks prior to creatine treatment initiation Exclusion Criteria: * Persons unable to provide adequate informed consent * Persons who are at clinically significant suicidal or homicidal risk * Primary substance-related diagnosis other than methamphetamine dependence or abuse * Positive pregnancy test (females only) * History of renal disease * Clinically significant medical or neurological illness identified by history, physical exam and laboratory testing * History of hypersensitivity reaction to creatine
Where it's running
-
Montana State University College of Nursing (Missoula campus)
Missoula, Montana, United States Recruiting
Study contacts
- Principal investigator: Tracy Hellem, PhD — Montana State University
- Study coordinator: Tracy Hellem, PhD
- Email: tracy.hellem1@montana.edu
- Phone: 406 243 2110
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
-
Tele-based wellbeing centres for women's mental health in Bangladesh
A randomized trial tests whether tele-counselling for depression and anxiety in Bangladeshi women is as effective as in-person counselling.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Focused ultrasound for mood and anxiety disorders
This study tests whether repeated low-intensity focused ultrasound using the ATTN201 device can help people with subsyndromal to moderate depression, anxiety, or OCD.
-
An Ultra-Brief ICBT Intervention with Personal Feedback for Depression and Anxiety
This trial tests whether adding personalized feedback about a person’s recent healthy actions to the Things You Do ultra-brief online CBT program helps adults with depression and anxiety do more healthy activities and feel better.
-
Virtual nature vs guided imagery for anxiety and well-being in hospitalized older adults
In this study, hospitalized adults 65 and older try two ways to bring nature to them: watching 360-degree nature videos on a VR headset or listening to a guided imagery audio to imagine the same scenes, to see which helps mood and anxiety during a two-week period.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.